A multinational pharmacoeconomic analysis of oral therapies for onychomycosis

Arikian SR, Einarson TR, Kobeltnguyen G, Schubert F, Allen R, Baran R, Bergman W, Bitetto L, Blattstein JS, Breda M, Clement W, et al. (1994)
British Journal of Dermatology 130(Suppl. 43): 35-44.

Konferenzbeitrag | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Arikian, SR; Einarson, TR; Kobeltnguyen, G; Schubert, F; Allen, R; Baran, R; Bergman, W; Bitetto, L; Blattstein, JS; Breda, M; Clement, W; De Cuyper, C
Alle
Abstract / Bemerkung
Due to increased interest in economic evaluation and the rapid international spread of new healthcare technologies across borders, there is a need to interpret economic evaluations on a worldwide basis. We conducted a multinational cost-effectiveness analysis, from a government payer perspective, comparing four primary oral treatment regimens for onychomycosis of the fingernails and toenails: griseofulvin, itraconazole, ketoconazole and terbinafine. We used a four-step pharmacoeconomic research model which includes all relevant factors affecting costs in 13 countries: Austria, Belgium, Canada, Finland, France, Germany, Greece, Italy, The Netherlands, Portugal, Spain, Switzerland and the U.K. A worldwide meta-analysis of published clinical data served as the statistical input for the pharmacoeconomic model, and demonstrated that terbinafine had the highest success rates (95.0% and 78.3%) of the clinical comparators for fingernails and toenails, respectively. We found that terbinafine was the most effective therapy in relation to cost (therefore giving it the lowest cost-effectiveness ratio) for both infections in all health-care systems analysed.
Erscheinungsjahr
1994
Serien- oder Zeitschriftentitel
British Journal of Dermatology
Band
130
Ausgabe
Suppl. 43
Seite(n)
35-44
Konferenz
Symposium on Lamisil: A New Measure in Antifungal Therapy in Skin and Nail Disease, at Dermatology 2000
Konferenzort
Vienna, Austria
Konferenzdatum
1993-05-18
ISSN
0007-0963
Page URI
https://pub.uni-bielefeld.de/record/2968837

Zitieren

Arikian SR, Einarson TR, Kobeltnguyen G, et al. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology. 1994;130(Suppl. 43):35-44.
Arikian, S. R., Einarson, T. R., Kobeltnguyen, G., Schubert, F., Allen, R., Baran, R., Bergman, W., et al. (1994). A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology, 130(Suppl. 43), 35-44. https://doi.org/10.1111/j.1365-2133.1994.tb06093.x
Arikian, SR, Einarson, TR, Kobeltnguyen, G, Schubert, F, Allen, R, Baran, R, Bergman, W, et al. 1994. “A multinational pharmacoeconomic analysis of oral therapies for onychomycosis”, British Journal of Dermatology, 130 (Suppl. 43): 35-44.
Arikian, S. R., Einarson, T. R., Kobeltnguyen, G., Schubert, F., Allen, R., Baran, R., Bergman, W., Bitetto, L., Blattstein, J. S., Breda, M., et al. (1994). A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology 130, 35-44.
Arikian, S.R., et al., 1994. A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology, 130(Suppl. 43), p 35-44.
S.R. Arikian, et al., “A multinational pharmacoeconomic analysis of oral therapies for onychomycosis”, British Journal of Dermatology, vol. 130, 1994, pp. 35-44.
Arikian, S.R., Einarson, T.R., Kobeltnguyen, G., Schubert, F., Allen, R., Baran, R., Bergman, W., Bitetto, L., Blattstein, J.S., Breda, M., Clement, W., De Cuyper, C., Difonzo, E., Van Doorstaer , E., Doyle, J.J., Effendy, I., Eichmann, A., Feuilhade, M., Figueiredo, A., Flori, Y.A., Germaine, G.E.R.M.A.I.N.E., Camarasa, J.M.G., Ginter, G., Gisbert, R., Goodfield, M., Groeneweg, D.A., Gunn, D., Hannuksela, M., Havu, V., Knappe, E., Koussidou- Eremonti, T., Lateur, N., Lee, R.E., Lucioni, C., Mathioudaki, E., Mikultis, R., Nolting, S., Panagiotidou, D., Pekurinen, M., Pereira, J., Rey, J.P., Pietrini, P., Soares, A.P., Pirard, C., Roberts, D.T., Rovira, J., Rufli, T., Rutten, F., Sommer, J.H., Spangler, E., Stary, A., Stavrianeas, N., Stavropoulos, P., Stubb, S., Taddio, A., Topolewski, K., Tosti, A., Yfantopoulos, J., Vagena, A., Van Hecke, E., Vareltzidis, A., Zalinski, J.: A multinational pharmacoeconomic analysis of oral therapies for onychomycosis. British Journal of Dermatology. 130, 35-44 (1994).
Arikian, SR, Einarson, TR, Kobeltnguyen, G, Schubert, F, Allen, R, Baran, R, Bergman, W, Bitetto, L, Blattstein, JS, Breda, M, Clement, W, De Cuyper, C, Difonzo, E, Van Doorstaer , E, Doyle, JJ, Effendy, Isaak, Eichmann, A, Feuilhade, M, Figueiredo, A, Flori, YA, Germaine, GERMAINE, Camarasa, JMG, Ginter, G, Gisbert, R, Goodfield, M, Groeneweg, DA, Gunn, D, Hannuksela, M, Havu, V, Knappe, E, Koussidou- Eremonti, T, Lateur, N, Lee, RE, Lucioni, C, Mathioudaki, E, Mikultis, R, Nolting, S, Panagiotidou, D, Pekurinen, M, Pereira, J, Rey, JP, Pietrini, P, Soares, AP, Pirard, C, Roberts, DT, Rovira, J, Rufli, T, Rutten, F, Sommer, JH, Spangler, E, Stary, A, Stavrianeas, N, Stavropoulos, P, Stubb, S, Taddio, A, Topolewski, K, Tosti, A, Yfantopoulos, J, Vagena, A, Van Hecke, E, Vareltzidis, A, and Zalinski, J. “A multinational pharmacoeconomic analysis of oral therapies for onychomycosis”. British Journal of Dermatology 130.Suppl. 43 (1994): 35-44.

Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 8186141
PubMed | Europe PMC

Suchen in

Google Scholar